Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169650 · ClinicalTrials.gov registry record
Laparoscopic Pyeloplasty Registry and Database
A clinical trial of Ureteral Obstruction, sponsored by Indiana Kidney Stone Institute.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT00169650: Completed study of Ureteral Obstruction, sponsored by Indiana Kidney Stone Institute.
NCT00169650 is a study of Ureteral Obstruction that has completed, run by Indiana Kidney Stone Institute. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169650, a study of Ureteral Obstruction, has completed, sponsored by Indiana Kidney Stone Institute.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The gold standard for the treatment of ureteropelvic junction obstruction (UPJO) is the open pyeloplasty. As a minimally invasive alternative, many centers are currently offering laparoscopic pyeloplasty (LP) as primary therapy for UPJOs. Recent data has shown that laparoscopic pyeloplasty has comparable success rates to open pyeloplasties and produces durable results. The researchers are compiling a registry and database to review outcomes of laparoscopic pyeloplasty patients.
Conditions Studied
Interventions
- OTHER Registry and database
Study Locations (1)
Indiana
- IU Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2003-07 |
| Est. Completion | 2016-12 |
What the finished NCT00169650 record still lists
NCT00169650 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 64 participants, a relatively small participant target.
The record links to 1 condition, with Ureteral Obstruction appearing as the primary indexed condition, and to 1 intervention - of which Registry and database is the first listed.
NCT00169650 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT00169650 about?
NCT00169650 is a clinical study titled "Laparoscopic Pyeloplasty Registry and Database". The gold standard for the treatment of ureteropelvic junction obstruction (UPJO) is the open pyeloplasty. As a minimally invasive alternative, many centers are currently offering laparoscopic pyeloplasty (LP) as primary therapy for UPJOs. Recent data has shown that laparoscopic pyeloplasty has compa...
What is the current status of trial NCT00169650?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2003-07. Estimated completion is 2016-12.
What conditions does trial NCT00169650 study?
This clinical trial studies the following conditions: Ureteral Obstruction.
What interventions are being tested in trial NCT00169650?
The interventions under investigation include: Registry and database (OTHER).
Who is sponsoring clinical trial NCT00169650?
This trial is sponsored by Indiana Kidney Stone Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169650 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ureteral Obstruction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia